top of page
NEWS


Poll: Iowans Say Healthcare Costs Are Rising — Lawmakers Aren’t Keeping Up
A new statewide poll commissioned by Iowans for Affordable Healthcare shows strong bipartisan concern about rising healthcare costs and growing skepticism that lawmakers are doing enough to address affordability. Nearly two-thirds of Iowans (61%) say their healthcare costs have increased, and 59% say federal lawmakers could be doing more to lower costs. At the state level, confidence is eroding: 49% say state legislators are not making the right decisions on healthcare prices
6 days ago2 min read


Who will be impacted by ACA tax subsidies expiring in the New Year?
By Isabella Warren Published: Dec. 23, 2025 at 6:00 PM CST DES MOINES, Iowa (Gray Media Iowa Capitol Bureau) - Millions of Americans will ring in the new year with higher healthcare premiums after Congress chose not to extend some of the Affordable Care Act’s tax subsidies before adjourning for the year. Bartenders, small business owners and farmers represent some of the millions of Americans expected to lose health care tax subsidies when enhanced Affordable Care Act credits
7 days ago2 min read


New nonpartisan group to advocate for polices to lower healthcare costs at Iowa Capitol
by Skylar Tallal Tue, November 11, 2025 at 5:45 PM DES MOINES, Iowa — While many Iowans are seeing their health care premiums increase, a new Iowa organization is pushing for policies to help lower costs. "There's just so much up in the air right now that people are, are nervous," Phil Jeneary the executive director of Iowans for Affordable Healthcare, said. Iowans for Affordable Healthcare is a new nonpartisan group advocating for policies that help Iowans obtain cost-frien
Nov 12, 20251 min read


US FDA proposes moves to speed availability of some cheaper biotech medicines
WASHINGTON, Oct 29 (Reuters) - The U.S. Food and Drug Administration on Wednesday said it is aiming to reduce the number of human clinical studies required for approval of certain biosimilar drugs and cut development costs for the medicines made using living cells. The agency released draft guidance proposing ways to accelerate the availability of less expensive close copies of complex biotech medicines and treat them like generics, enabling doctors to prescribe them more eas
Oct 30, 20252 min read
bottom of page
